Skip to main content

Table 3 Comparisons of the mean The Athens Insomnia Scale grading regarding the different disease parameters among the studied RA patients

From: A comparative study between rheumatoid arthritis and osteoarthritis regarding association of insomnia with disease status

Variables

None (n = 5)

Mild (n = 8)

Moderate/severe (n = 7)

P value

Age (years)

(mean ± SD)

40.8 ± 8.89

47.25 ± 8.84

42.29 ± 8.99

0.395

Sex

no. (%)

 Female

3 (60)

6 (75)

7 (100)

0.21

 Male

2 (40)

2 (25)

0 (0)

 

Disease duration

Median (IQR)

6 (4–12)

11.5 (6.5–18.5)

5 (2–15)

0.350

Morning stiffness/minutes

median (IQR)

60 (60–90)

120 (60–120)

120 (60–120)

0.371

Tender joints

median (IQR)

3 (2–6)

6.5 (3–9.25)

12 (10–15)

< 0.001**

Swollen joint

median (IQR)

1 (0–1)

1 (0–3.75)

4 (2–5)

0.013**

Rheumatoid nodules no. (%)

1 (20)

5 (62.5)

5 (71.4)

0.2

Chest symptoms. (%)

0 (0)

2 (25)

0 (0)

0.2

Sicca symptoms (%)

0 (0)

1 (12.5)

1 (14.3)

0.7

DAS 28

median (IQR)

4.03 (3.08–4.6)

4.4 (3.9–5.1)

5.3 (5.04–6.1)

0.004**

Simple Erosion Narrowing Score

median (IQR)

18 (10–28)

21 (13.3–36.5)

20 (11–30)

0.659

Hemoglobin (g\dl)

11.8 ± 1.6

11.4 ± 1.3

11.01 ± 1.4

0.63

ESR median (IQR)

45 (23.5–70)

47.5 (31.25–107.5)

70 (30–90)

0.64

CRP median (IQR)

6 (3.5–38.5)

12 (6–42)

6 (5–48)

0.95

RF median (IQR)

64 (14–173)

64 (20–117)

128 (64–128)

0.71

Anti-CCP

median (IQR)

30 (20–139)

30 (19–90)

265 (145–355.5)

< 0.001**

  1. ESR Erythrocyte sedimentation rate, CRP C-reactive protein, RF Rheumatoid factor, Anti-CCP Anti-cyclic citrullinated peptide. p ≥ 0.05 = non-significant, p ≤ 0.001** = highly significant. One-way ANOVA (f) test, Fisher’s exact test, chi-square test